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colony count reduction with the wipes was significantly
greater than with the hand rub (Pp .001, by the Mann-
Whitney U test).
Most of the cultured bacteria were normal skin flora, such
as coagulase-negative staphylococci. Seventeen stethoscopes
(20%) grew S. aureus, one isolate of which was methicillin-
resistant S. aureus. One culture yielded Enterococcus species,
and 1 yielded Enterobacter aerogenes. For those stethoscopes
that harbored S. aureus, the median colony count was 5 CFU
(range, 1–30 CFU). Both cleaning methods effectively re-
duced S. aureus colonization. Eradication of S. aureus was
achieved on 3 of 4 stethoscopes in the alcohol wipe group
and on 7 of 13 in the hand rub group (Pp .603, by the
Fisher exact test).
Our data confirmed that stethoscope contamination with
bacterial pathogens, including S. aureus, is common. A single
cleaning of stethoscopes with alcohol-based hand rub reduced
bacterial contamination of stethoscopes by approximately 90%
and was 54% successful in eradicating S. aureus. Routine use
of the alcohol products on stethoscopes may be more effective
in reducing bacterial contamination than a single application.
At this time, there are no data on the long-term impact of
repeated alcohol applications on stethoscope integrity.
These data also show that a single cleaning with an alcohol
wipe was more effective than the alcohol-based hand rub in
decontamination of stethoscopes, possibly because of the me-
chanical effect of the cotton pledget. However, given tradi-
tionally poor compliance with hand hygiene, advocating rou-
tine use of a second procedure involving alcohol wipes to
disinfect stethoscopes is impractical and unlikely to be per-
formed reliably. With the wide availability of alcohol-based
hand rub, the combination of hand and stethoscope rubbing
in a single maneuver has practical appeal and, if the prelim-
inary findings of this study are confirmed, could become part
of routine bedside practice.
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Comparison of Costs of Surgical Site
Infection and Endometritis after Cesarean
Delivery Using Claims and Medical Record
Data
We used administrative and clinical data from a case-control study
to calculate the costs of surgical site infection and endometritis after
cesarean delivery. Attributable costs determined by multivariate gen-
eralized least-squares regression models with the 2 data sets were
similar, suggesting that administrative data can be used to calculate
infection costs.
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Calculation of the attributable costs due to hospital-acquired
infection requires adjustment for factors associated both with
infection and with increased or decreased costs. In many re-
ports, attributable costs are determined using multivariate
models or matching algorithms adjusted for demographic
characteristics, comorbidities, and procedure-associated data
abstracted from medical records.1,2 Alternatively, we and oth-
ers have used administrative data (primarily The Internation-
al Classification of Diseases, 9th Edition, Clinical Modification
[ICD-9-CM] diagnosis and procedure codes) to define co-
morbidities and procedures.3,4 To our knowledge, no investi-
gators have compared the use of medical record versus claims
data to determine the attributable costs of a hospital-acquired
infection. We used the 2 sources of data to create covariates
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for regression models, which we constructed to calculate costs
attributable to surgical site infection (SSI) and endometritis
among women who underwent cesarean delivery.
We performed a case-control study on a subset of 491
women who underwent low transverse cesarean delivery at
Barnes-Jewish Hospital, a 1,250-bed tertiary care hospital af-
filiated with Washington University School of Medicine (St
Louis, MO) during the period July 1, 1999 through June 30,
2001. We previously reported independent risk factors for SSI
and endometritis in this population.5,6 Endometritis was con-
sidered to be present if there was fever that began more than
24 hours after or continued at least 24 hours after delivery,
as well as fundal tenderness.6 SSI was defined on the basis of
the criteria of the National Nosocomial Infections Surveil-
lance System.5,8
Electronic data were collected for all patients from the
Barnes-Jewish Hospital Medical Informatics database for the
original surgical admission, including demographic infor-
mation, microbiology and laboratory test results, and ICD-
9-CM diagnosis and procedure codes. ICD-9-CM diagnosis
codes were also collected for the 12 months preceding the
cesarean delivery to identify comorbidities. Comorbidity and
procedure variables were created from the administrative data
using the Clinical Classification diagnostic groupings, which
are available at the Web site of the Healthcare Cost and Uti-
lization Project.7
Clinical data, including obstetric history, relevant comor-
bidities thought to be associated with risk of SSI or endome-
tritis, prophylactic and therapeutic antibiotics, and duration
of rupture of membranes and labor, were collected from the
surgical hospitalization records as described previously.5,6
Total hospital cost data (direct, indirect, and fixed costs)
were obtained from the Barnes-Jewish Hospital cost account-
ing database (Trendstar; McKesson) for the surgical admis-
sion and any inpatient surgery, outpatient surgery, and emer-
gency readmission to the hospital within 30 days after surgery,
excluding the costs before the day of the cesarean delivery,
as described previously.9 All costs were inflation adjusted to
2008 US dollars using the medical care component of the
Consumer Price Index.10
Attributable costs were determined as previously described
using multivariate generalized least-squares (GLS) regres-
sion.3,9,11 All variables with P value less than or equal to .05
in univariate analysis or with biologic plausibility were en-
tered into the initial model; P values greater than .25 were
used for exclusion in the model. An intermediate regression
was performed to predict costs in 2008 US dollars.11 Attrib-
utable costs were calculated from the coefficients in the GLS
model, as described elsewhere.3,9 All statistical analyses were
performed using Stata software, version 9.2 (Stata Corp). Ap-
proval for this study was obtained from the Washington Uni-
versity Human Research Protection Office.
The study population was restricted to women with com-
plete cost data for the original surgical hospitalization and
any additional hospitalization(s) within 30 days after low
transverse cesarean delivery. The population included 80
women with SSI, 121 women with endometritis, and 309
control patients without infection. Nineteen women had both
SSI and endometritis.
Separate GLS models were created to determine the impact
of SSI and endometritis on hospital costs using the 2 sources
of data (administrative data and medical records) to identify
covariates. In the administrative data model, covariates asso-
ciated with significantly increased costs were young age, severe
complications of delivery, pneumonia, pulmonary collapse or
insufficiencies, preeclampsia or eclampsia, chorioamnionitis,
maternal cardiac conditions, sexually transmitted infection,
obstetric laceration and/or trauma, ovarian procedures, and
placement of a central venous catheter. In the alternative
model using medical record data, covariates associated with
significantly increased costs included age, nonwhite race, la-
bor induction, use of drains, additional surgical procedure
other than bilateral tubal ligation, transfusion and/or anemia,
severe preeclampsia or eclampsia, use of general anesthesia,
inhaled steroids, preoperative antibiotics for therapy of cho-
rioamnionitis, and postoperative hematoma. The attributable
costs of SSI and endometritis estimated by the 2 multivariate
GLS regression models were very similar, regardless of the
source of data used to specify covariates (Table 1).
We compared attributable costs of SSI and endometritis
after cesarean delivery calculated using electronically available
administrative and demographic data with costs calculated
using manually collected medical record data to specify model
covariates. The estimated attributable costs calculated using
GLS regression models for both SSI and endometritis were
similar, regardless of the source of data used to specify co-
variates. This finding suggests that administrative data can
be used to estimate costs of these hospital-acquired infections.
Administrative data are available from many institutions with
diverse patient populations through the Healthcare Cost and
Utilization Project. Our results suggest that these data can be
used to determine variation in costs of infection by institution
and by type of surgery.
We determined that the costs of SSI equaled $3,400–$3,700
and the costs of endometritis equaled $3,800–$4,000. These
costs differ slightly from those reported in our previous study
of infection costs after cesarean delivery,9 because of the use
of a case-control subset in this report, compared with use of
the entire cohort of 1,597 women in the previous study. Our
finding that administrative data could be used instead of clin-
ical medical record data in our tertiary care institution to
specify covariates in regression models must be confirmed
with data from other facilities representing the great variety
of acute care hospitals in the United States. Use of admin-
istrative data will facilitate comparison of costs of infection
across facilities and can be used in the future to determine
the economic impact of infection control prevention activities
in institutions and at state and national levels.
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table 1. Coefficients from the 2 Generalized Least-Squares Models Using Administrative and Medical Record Data to Determine
Attributable Costs of Surgical Site Infection and Endometritis
Variable
Administrative data Medical record data
Value P Value P
Surgical site infection 0.36  0.04 !.001 0.36  0.04 !.001
Endometritis 0.40  0.03 !.001 0.35  0.03 !.001
Age
!18 years 0.10  0.05 .053 0.12  0.05 .022
135 years 0.07  0.04 .113 0.12  0.04 .004
Nonprivate health insurancea 0.03  0.03 .256 …
Nonwhite race … 0.10  0.03 .002
Sexually transmitted disease 0.38  0.15 .013 …
Diabetes mellitus or gestational diabetes 0.07  0.05 .142 …
Maternal heart disease 0.18  0.07 .011 …
Labor induction … 0.06  0.03 .039
Drains … 0.23  0.05 !.001
Ovarian surgical procedure 0.46  0.14 .001 …
Surgical procedure other than bilateral tubal ligation … 0.23  0.07 .001
Obstetric laceration 0.28  0.11 .013 …
Severe complication of delivery 0.52  0.11 !.001 …
Central venous catheterb 0.54  0.11 !.001 …
Mild preeclampsia 0.12  0.05 .017 0.06  0.05 .203
Severe preeclampsia or eclampsia 0.27  0.05 !.001 0.16  0.05 .001
General anesthesia 0.22  0.05 !.001
Clinical diagnosis of chorioamnionitis 0.20  0.04 !.001 …
Antibiotic prophylaxis against group B Streptococcus (ampicillin, peni-
cillin, or clindamycin) … 0.06  0.03 .092
Antibiotic therapy before surgery for chorioamnionitis (gentamicin, to-
bramycin, or ampicillin-sulbactam) … 0.18  0.04 !.001
Pneumonia 0.31  0.10 .002 …
Pulmonary collapse or insufficiencies 0.30  0.12 .015 …
Transfusion and/or anemia … 0.20  0.03 !.001
Postoperative hematoma … 0.20  0.07 .006
Inhaled steroid therapy … 0.30  0.10 .003
R2 for the modelc 0.31 0.30
Attributable cost, mean 2008 US$ (95% CI)
Surgical site infection $3,418 ($2,863–$4,081) $3,684 ($2,867–$4,734)
Endometritis $3,794 ($3,177–$4,530) $4,015 ($3,075–$5,243)
note. Data are estimated b coefficient  standard error, unless otherwise indicated. CI, confidence interval.
a Public Aid, Medicaid, Medicare, or no health insurance.
b Inserted before the onset of surgical site infection and/or endometritis in case patients.
c Adjusted R2 after accounting for the natural log transformation of costs.
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Sustained and Prolonged Reduction
in Central Line–Associated Bloodstream
Infections as a Result of Multiple
Interventions
Healthcare-associated bloodstream infections are a major
source of morbidity and mortality among hospitalized pa-
tients. It has been estimated that 133,368 healthcare-associ-
ated bloodstream infections (BSIs) occur each year in the
United States, resulting in 30,665 deaths. The major risk fac-
tor for healthcare-associated BSIs is a central venous catheter;
an estimated 80,000 central venous catheter–associated BSIs
occur in intensive care units (ICUs) each year.1 Authoritative
guidelines have been published that provide recommenda-
tions designed to reduce the rate of central line–associated
(CLA) BSI.1,2 In addition, the Institute for Healthcare Quality
and Improvement promulgated a “bundle” of control mea-
sures that used feedback of process measures to further re-
duce CLABSI.3
A comparison of data reported by National Healthcare
Safety Network (2006–2007)4 with data reported by the Na-
tional Nosocomial Infection Surveillance system (1992–
2004)5 demonstrates a reduction in the rate of CLABSIs over
this time period in all ICUs. A large intervention study that
used a before-and-after design demonstrated a dramatic re-
duction in the rate of CLABSI over 16–18 months by im-
plementation of an infection control bundle of hand hygiene,
full-barrier precautions during central line insertion, skin an-
tisepsis with chlorhexidine, avoidance of the femoral cathe-
terization site, and removal of unnecessary catheters.6 How-
ever, only limited data are available that demonstrate a
prolonged and sustained reduction of CLABSI in which this
decrease correlates with specific intervention efforts. Here, we
report data from the University of North Carolina Hospitals,
an 800-bed tertiary care facility, that demonstrate a dramatic
decrease in the rate of CLABSI over a 10-year period.
Infection control at University of North Carolina Hospitals
is provided by 2 faculty members, 6 infection preventionists,
1 public health epidemiologist, and 1 laboratory technologist.
Comprehensive hospital-wide surveillance was conducted us-
ing definitions recommended by the National Nosocomi-
al Infection Surveillance7 and, more recently, the National
Healthcare Safety Network.8 All data were entered into a com-
puterized database. Rates of CLABSI were calculated as the
number of infections per 1,000 central line–days. Simple lin-
ear regression models (least-squares method) were used to
examine decreases in the rate of CLABSI over time. Statistical
significance was assessed by comparing these regression lines
to a line with a zero slope. On the basis of the decreased
CLABSI rates, we calculated the number of CLABSIs pre-
vented and the estimated cost savings associated with the
decrease.
Over the 10 years period from 1999 to 2008, the number
of CLABSIs decreased 73% (P ! .001) for all the ICUs com-
bined (Figure 1). Rates in individual ICUs were as follows
(1999, 2008, statistical assessment of decrease): neonatal ICU
rates for 1999 and 2008, 9.0 and 3.1, respectively (Pp .012);
pediatric ICU rates for 1999 and 2008, 7.8 and 4.1, respec-
tively (Pp .013); coronary care ICU rates for 1999 and 2008,
2.7 and 2.5, respectively (Pp .33); surgery or trauma ICU
rates for 1999 and 2008, 14.1 and 2.7, respectively (Pp .003);
neurosurgery ICU rates for 1999 and 2008, 12.7 and 3.0,
respectively (Pp .068); cardiothoracic ICU rates for 1999
and 2008, 7.4 and 0.8, respectively (P ! .001); burn ICU rates
for 1999 and 2008, 14.1 and 1.1, respectively (P ! .001); and
medicine or respiratory ICU rates for 1999 and 2008, 6.1 and
1.6, respectively (P ! .001). Over the 10-year time period
1999–2008, we prevented 887 infections at a total cost savings
of $20,615,654, based on published cost data and 244 deaths.9
The unit specific rates of CLABSI have been reported quar-
terly to medical and nursing directors since 1999. Multiple
interventions were introduced during the past 10 years to aid
in reducing the rate of CLABSI:
